Xynomic

Xynomic Starts Ph III Trial of Abexinostat in Renal Cell Carcinoma
CP Wire
Tue, 02/26/19 - 10:04 am
Xynomic
Abexinostat
renal cell carcinoma
Xynomic Starts Ph III Trial of Abexinostat in Renal Cell Carcinoma
Tue, 02/26/19 - 10:02 am
Xynomic
Abexinostat
renal cell carcinoma
Boehringer offloads an mTOR cancer drug as Xynomic plots a quick advance in the clinic
Endpoints
Fri, 12/21/18 - 10:15 am
Boehringer Ingelheim
R&D
Xynomic
mTOR